IN-VIVO ISOPROTERENOL TREATMENT LEADS TO DOWN-REGULATION OF THE MESSENGER-RNA ENCODING THE CAMP RESPONSE ELEMENT-BINDING PROTEIN IN THE RAT-HEART

被引:17
作者
MULLER, FU
BOKNIK, P
HORST, A
KNAPP, J
LINCK, B
SCHMITZ, W
VAHLENSIECK, U
WALTER, A
机构
[1] Institut für Pharmakologie und Toxikologie, Universität Münster
关键词
D O I
10.1006/bbrc.1995.2569
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of different myocardial regulatory proteins is altered in human heart failure, e.g., beta(1)-adrenoceptors, G-proteins and others. Similar changes in rats after 4 days treatment with isoproterenol led to the hypothesis of the cAMP pathway involved in these changes. In different cell types cAMP-dependent transcriptional activation is mediated by the cAMP-response element binding protein (CREB) which was recently shown to be expressed and phosphorylated in the human heart. Here, by the reverse transcriptase-polymerase chain reaction two alternatively spliced isoforms of CREB mRNA were found to be expressed in rat ventricles. Both isoforms were downregulated in the ventricles of rats treated in vivo with isoproterenol (2.4 mg/kg per day) for 4 days proposing a possible mechanism involved in expressional changes mentioned above. (C) 1995 Academic Press, Inc.
引用
收藏
页码:1043 / 1049
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 1994, CIRCULATION, V90, P1765
[2]   2 DISTINCT FORMS OF ACTIVE TRANSCRIPTION FACTOR CREB (CAMP RESPONSE ELEMENT BINDING-PROTEIN) [J].
BERKOWITZ, LA ;
GILMAN, MZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (14) :5258-5262
[3]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]  
DALY PA, 1990, CIRCULATION, V82, P35
[6]  
ESCHENHAGEN T, 1991, N-S ARCH PHARMACOL, V343, P609
[7]  
ESCHENHAGEN T, 1992, MOL PHARMACOL, V42, P773
[8]   INCREASED MESSENGER-RNA LEVEL OF THE INHIBITORY-G PROTEIN ALPHA-SUBUNIT GI-ALPHA-2 IN HUMAN END-STAGE HEART-FAILURE [J].
ESCHENHAGEN, T ;
MENDE, U ;
NOSE, M ;
SCHMITZ, W ;
SCHOLZ, H ;
HAVERICH, A ;
HIRT, S ;
DORING, V ;
KALMAR, P ;
HOPPNER, W ;
SEITZ, HJ .
CIRCULATION RESEARCH, 1992, 70 (04) :688-696
[9]   ALTERED EXPRESSION OF ALPHA-SUBUNITS OF G-PROTEINS IN FAILING HUMAN HEARTS [J].
FELDMAN, AM ;
CATES, AE ;
BRISTOW, MR ;
VANDOP, C .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1989, 21 (04) :359-365
[10]   SELECTIVE GENE-EXPRESSION IN FAILING HUMAN HEART - QUANTIFICATION OF STEADY-STATE LEVELS OF MESSENGER-RNA IN ENDOMYOCARDIAL BIOPSIES USING THE POLYMERASE CHAIN-REACTION [J].
FELDMAN, AM ;
RAY, PE ;
SILAN, CM ;
MERCER, JA ;
MINOBE, W ;
BRISTOW, MR .
CIRCULATION, 1991, 83 (06) :1866-1872